NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered BPC-157 from Xingruida XDR? Mail in a sample (US only) and let us test it.

Test my supply
+4 more ↓
54%
Finnrick rating
#43 of 149 BPC-157 vendors
5 of 8 classifiable tests passed
natural 63% · customers 4.2★ (3)
methodology · Purity focus
Finnrick analysis · BPC-157

Mixed purity and fill history keeps this profile moderate: misses include 99.37% and May's 99.0% purity, plus a 98.6% batch with +39% fill. Identity passed throughout, but the trajectory remains uneven.

methodology →
vendor intelligence report
Vendor Intelligence Report: Xingruida XDR

Corporate filings trace a dissolved UK namesake and a live Hong Kong layer without resolving the storefront’s controller. The report also maps shared-hosting overlap with Mammoth Biotech and a brand-keyword WhatsApp doorway network.

38 pages8 risk factors assessed12 Nov 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Tirzepatide
$0.33
79%
24
2
Retatrutide
$0.99
78%
32
3
Ipamorelin
$0.90
73%
3
4
GHK-Cu
$0.08
71%
9
5
Melanotan II
$0.58
61%
2
6
PT-141
-
60%
3
7
Tesamorelin
$2.42
55%
10
8
BPC-157selected
$1.04
54%
8
9
TB-500
$1.74
43%
3
10
Cagrilintide
$3.38
-
0
12
Semaglutide
$2.14
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%24 Jul 2025: 36%31 Jul 2025: 33%14 Oct 2025: 43%25 Nov 2025: 48%11 Dec 2025: 51%15 Jan 2026: 49%26 Feb 2026: 54%27 May 2026: 53%15 Nov 2026: current 54%36%49%54%Jul 25Nov 26
Showing BPC-157 tests only
Xingruida XDR BPC-157 test history
COA-backed lab tests

About Xingruida XDR test results from Finnrick

Xingruida XDR is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 9 peptides and 94 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Xingruida XDR peptides in this dataset are BPC-157 (8 tests), GHK-Cu (9 tests) and Ipamorelin (3 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 94 recent tests.

Corrections
No corrections.
Peptide testing

Ordered BPC-157 from Xingruida XDR? Mail in a sample (US only) and let us test it.

Test my supply